IMAQEN
Imaqen Ltd. is a Finnish healthcare technology company developing a new pre-screening solution for early detection of cancer. The innovation offers a non-invasive patient examination and it is suitable for use in wide range of healthcare facilities. The utilised method is protected by patents. Their team consists of experienced diagnostic imaging and clinical research professionals with solid track records in successful product development and global sales and marketing.
IMAQEN
Industry:
Biotechnology Health Care Information Technology Medical
Founded:
2016-01-01
Address:
Helsinki, Southern Finland, Finland
Country:
Finland
Website Url:
http://www.imaqen.com
Total Employee:
1+
Status:
Active
Contact:
+358 44 721 0530
Total Funding:
50 K EUR
Technology used in webpage:
SPF Google Font API LetsEncrypt Content Delivery Network Domain Not Resolving Google Apps For Business Google Maps ReCAPTCHA JsDelivr AJAX Libraries API
Similar Organizations
BIND Therapeutics
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
HealthLytix
HealthLytix is a healthcare technology company using genomics and medical imaging to revolutionize screening and early detection of disease
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Employees Featured
Founder
Investors List
European Innovation Council
European Innovation Council investment in Grant - Imaqen
Official Site Inspections
http://www.imaqen.com
- Host name: starfish.surfnet.fi
- IP address: 93.91.178.52
- Location: Finland
- Latitude: 60.1717
- Longitude: 24.9349
- Timezone: Europe/Helsinki
